| Mechanisms and therapeutic implications of hypermutation in gliomas M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ... Nature 580 (7804), 517-523, 2020 | 450 | 2020 |
| Recurrent glioblastoma: from molecular landscape to new treatment perspectives C Birzu, P French, M Caccese, G Cerretti, A Idbaih, V Zagonel, ... Cancers 13 (1), 47, 2020 | 139 | 2020 |
| Immune checkpoint inhibitors‐induced neuromuscular toxicity: from pathogenesis to treatment D Psimaras, R Velasco, C Birzu, S Tamburin, M Lustberg, J Bruna, ... Journal of the Peripheral Nervous System 24, S74-S85, 2019 | 83 | 2019 |
| Molecular alterations in meningioma: prognostic and therapeutic perspectives C Birzu, M Peyre, F Sahm Current Opinion in Oncology 32 (6), 613-622, 2020 | 68 | 2020 |
| Leptomeningeal spread in glioblastoma: diagnostic and therapeutic challenges C Birzu, S Tran, F Bielle, M Touat, K Mokhtari, N Younan, D Psimaras, ... The Oncologist 25 (11), e1763-e1776, 2020 | 38 | 2020 |
| Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity A Farina, C Birzu, MH Elsensohn, A Picca, S Muñiz-Castrillo, A Vogrig, ... Brain Communications 5 (3), fcad169, 2023 | 17 | 2023 |
| Anti–Interleukin-6 and Janus Kinase inhibitors for severe neurologic toxicity of checkpoint inhibitors A Picca, N Valyraki, C Birzu, N Kramkimel, O Hermine, N Zahr, G Berzero, ... Neurology: Neuroimmunology & Neuroinflammation 8 (6), e1073, 2021 | 16 | 2021 |
| Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis NL Ciano-Petersen, S Muñiz-Castrillo, C Birzu, A Vogrig, A Farina, ... Brain Communications 4 (4), fcac196, 2022 | 11 | 2022 |
| Dramatic response of STRN-NTRK-fused malignant glioneuronal tumor to larotrectinib in adult J Boyer, C Birzu, F Bielle, C Goulas, J Savatovsky, C Karachi, A Idbaih Neuro-oncology 23 (7), 1200-1202, 2021 | 11 | 2021 |
| Peripheral neuropathies after BRAF and/or MEK inhibitor treatment: a pharmacovigilance study A Picca, C Birzu, G Berzero, P Sanchez‐Pena, L Gaboriau, F Vidil, ... British Journal of Clinical Pharmacology 88 (11), 4941-4949, 2022 | 7 | 2022 |
| Meningiomas: A review of current knowledge J Boetto, C Birzu, M Kalamarides, M Peyre, M Sanson La Revue de Medecine Interne 43 (2), 98-105, 2021 | 6 | 2021 |
| Brain Metabolic Alterations in Seropositive Autoimmune Encephalitis: An 18F-FDG PET Study S Bergeret, C Birzu, P Meneret, A Giron, S Demeret, C Marois, L Cousyn, ... Biomedicines 11 (2), 506, 2023 | 4 | 2023 |
| Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells M Gazzano, C Parizot, D Psimaras, A Vozy, M Baron, B Abbar, V Fallet, ... Frontiers in Immunology 13, 1082084, 2022 | 4 | 2022 |
| OS9. 1 Clinical significance of hypermutation in gliomas M Touat, Y Li, A Boynton, L Spurr, B Iorglescu, J Geduldig, C Birzu, ML Fat, ... Neuro-oncology 21 (Suppl 3), iii18, 2019 | 2 | 2019 |
| Impact of anti-PD-1 therapy in a melanoma patient with paraneoplastic anti-ITPR1 encephalitis F Brunet-Possenti, C Birzu, L Deschamps, S Hacein-Bey-Abina, ... Revue neurologique 180 (3), 216-217, 2024 | 1 | 2024 |
| Impact of immune checkpoint inhibitors on the course of multiple sclerosis G Androdias, L Noroy, D Psimaras, C Birzu, J Pelletier, Y Beigneux, ... Neurology: Neuroimmunology & Neuroinflammation 11 (2), e200202, 2024 | 1 | 2024 |
| Late-onset vascular complications of radiotherapy for primary brain tumors: a case–control and cross-sectional analysis MJ Ibáñez-Juliá, A Picca, D Leclercq, G Berzero, J Jacob, L Feuvret, ... Journal of Cancer Survivorship 18 (1), 59-67, 2024 | 1 | 2024 |
| Les méningiomes: mise au point sur les connaissances actuelles J Boetto, C Birzu, M Kalamarides, M Peyre, M Sanson La Revue de Médecine Interne 43 (2), 98-105, 2022 | 1 | 2022 |
| Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives. Cancers 2021, 13, 47 C Birzu, P French, M Caccese, G Cerretti, A Idbaih, V Zagonel, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2020 | 1 | 2020 |
| P14. 126 radiation-induced optic neuropathy A Thomas, C Birzu, L Feuvret, G Noël, K Hoang-Xuan, J Savatosky, ... Neuro-oncology 21 (Supplement_3), iii98-iii99, 2019 | 1 | 2019 |
Marc SansonNeurologist, Sorbonne-UniversitéVerified email at aphp.fr
